acadesine has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bontemps, F; Van den Berghe, G; Van Den Neste, E | 1 |
1 review(s) available for acadesine and Hematologic Malignancies
| Article | Year |
|---|---|
AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Clinical Trials as Topic; Enzyme Activation; Hematologic Neoplasms; Humans; Ribonucleosides | 2010 |